X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15321) 15321
Book Review (3648) 3648
Publication (1343) 1343
Book Chapter (178) 178
Book / eBook (120) 120
Conference Proceeding (48) 48
Dissertation (37) 37
Magazine Article (14) 14
Government Document (3) 3
Journal / eJournal (3) 3
Web Resource (3) 3
Data Set (1) 1
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13279) 13279
humans (11465) 11465
female (9141) 9141
antineoplastic agents, hormonal - therapeutic use (5541) 5541
oncology (5081) 5081
breast neoplasms - drug therapy (4352) 4352
middle aged (3803) 3803
male (3751) 3751
breast cancer (3678) 3678
animals (3514) 3514
aged (3042) 3042
adult (3000) 3000
tamoxifen (2901) 2901
cancer (2423) 2423
tamoxifen - therapeutic use (2353) 2353
breast neoplasms - pathology (2148) 2148
antineoplastic agents, hormonal - pharmacology (2124) 2124
treatment outcome (1905) 1905
estrogen (1727) 1727
postmenopausal women (1681) 1681
endocrinology & metabolism (1591) 1591
care and treatment (1567) 1567
breast neoplasms - metabolism (1439) 1439
expression (1427) 1427
chemotherapy, adjuvant (1402) 1402
women (1379) 1379
antineoplastic agents, hormonal - adverse effects (1373) 1373
research (1316) 1316
antineoplastic agents, hormonal - administration & dosage (1299) 1299
chemotherapy (1299) 1299
aged, 80 and over (1246) 1246
prognosis (1221) 1221
health aspects (1217) 1217
medicine & public health (1206) 1206
therapy (1170) 1170
analysis (1131) 1131
mice (1128) 1128
hormonal-regulation (1120) 1120
prostate cancer (1118) 1118
endocrine therapy (1106) 1106
risk factors (1104) 1104
obstetrics & gynecology (1083) 1083
rats (1062) 1062
abridged index medicus (1049) 1049
prostatic neoplasms - drug therapy (1042) 1042
receptors, estrogen - metabolism (1042) 1042
tamoxifen - pharmacology (1039) 1039
hormones (967) 967
breast neoplasms - genetics (949) 949
cell line, tumor (925) 925
biochemistry & molecular biology (916) 916
carcinoma (886) 886
pharmacology & pharmacy (882) 882
aromatase inhibitors (878) 878
antineoplastic combined chemotherapy protocols - therapeutic use (875) 875
disease-free survival (862) 862
postmenopause (858) 858
immunohistochemistry (821) 821
time factors (797) 797
drug therapy (780) 780
neoplasm staging (772) 772
estrogen-receptor (762) 762
drug resistance, neoplasm (757) 757
aromatase inhibitors - therapeutic use (754) 754
article (752) 752
breast neoplasms - mortality (748) 748
cell biology (747) 747
gene expression (729) 729
tumors (729) 729
cells (726) 726
gene-expression (724) 724
randomized-trial (723) 723
retrospective studies (723) 723
urology & nephrology (704) 704
hormonal therapy (703) 703
survival (664) 664
tamoxifen - adverse effects (662) 662
physiological aspects (657) 657
tamoxifen - administration & dosage (657) 657
progesterone (656) 656
surgery (654) 654
risk (648) 648
pregnancy (641) 641
prostatic neoplasms - pathology (634) 634
testosterone (630) 630
breast neoplasms - surgery (620) 620
hormonal-therapy (616) 616
neoplasms, hormone-dependent - drug therapy (614) 614
apoptosis (608) 608
metastasis (603) 603
menopause (602) 602
growth (595) 595
follow-up studies (594) 594
breast-cancer (593) 593
hematology, oncology and palliative medicine (592) 592
androgen antagonists - therapeutic use (591) 591
survival analysis (571) 571
anastrozole (569) 569
receptor (567) 567
receptors (567) 567
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (69) 69
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Online Resources - Online (8) 8
UofT at Mississauga - Stacks (6) 6
St. Michael's Hospital - Stacks (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Gerstein Science - Periodical Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
Scarborough Hospital - General (2) 2
St Josephs Health Centre - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Women's College Hospital - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Chemistry (A D Allen) - Stacks (1) 1
Gerstein Science - Bindery (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Royal Ontario Museum - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Toronto East General Hospital - Online (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Scarborough - Withdrawn (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14970) 14970
French (198) 198
Japanese (93) 93
Spanish (79) 79
German (74) 74
Russian (47) 47
Chinese (42) 42
Italian (40) 40
Portuguese (34) 34
Hungarian (24) 24
Polish (11) 11
Czech (9) 9
Danish (8) 8
Dutch (6) 6
Croatian (4) 4
Finnish (3) 3
Korean (3) 3
Romanian (3) 3
Serbian (3) 3
Slovak (2) 2
Slovenian (2) 2
Swedish (2) 2
Afrikaans (1) 1
Bulgarian (1) 1
Hebrew (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
2003, Methods in enzymology, ISBN 9780121822675, Volume 364, xliv, 536 p., [20] p. of plates
Nuclear Receptors are inducible transcription factors that mediate complex effects on development, differentiation and homeostasis. They regulate the... 
Receptors, Cytoplasmic and Nuclear | Receptor-ligand complexes | Nuclear receptors (Biochemistry) | Hormone receptors | Handbooks, manuals, etc
Book
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 33, pp. 5529 - 5537
Purpose TAnDEM is the first randomized phase III study to combine a hormonal agent and trastuzumab without chemotherapy as treatment for human epidermal growth... 
TRIAL | AROMATASE INHIBITOR | THERAPY | ONCOLOGY | SERUM HER-2/NEU | TAMOXIFEN | RESISTANCE | HER2 | COMBINATION | ESTROGEN-RECEPTOR | ENDOCRINE TREATMENT | Receptors, Estrogen - blood | Triazoles - administration & dosage | Triazoles - adverse effects | Confidence Intervals | Postmenopause - drug effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Nitriles - administration & dosage | Antibodies, Monoclonal, Humanized | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Metastasis | Adenocarcinoma - metabolism | Statistics, Nonparametric | Aged, 80 and over | Female | Drug Administration Schedule | Administration, Oral | Antineoplastic Agents, Hormonal - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Adenocarcinoma - secondary | Biomarkers, Tumor - blood | Disease-Free Survival | Maximum Tolerated Dose | Antibodies, Monoclonal - administration & dosage | Breast Neoplasms - pathology | Survival Analysis | Breast Neoplasms - mortality | Aged | Infusions, Intravenous | Nitriles - adverse effects | Receptors, Progesterone - blood | Receptor, ErbB-2 - blood | Trastuzumab | Adenocarcinoma - mortality | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 10/2008, Volume 100, Issue 19, pp. 1380 - 1388
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2012, Volume 7, Issue 10, pp. e45767 - e45767
Introduction: Estrogens regulate the proliferation of normal and neoplastic breast epithelium. Although the intracellular mechanisms of estrogens in the breast... 
MAMMARY EPITHELIAL ACINI | GROWTH-FACTOR RECEPTOR | ACTIVATION | CANCER CELLS | E-SCREEN ASSAY | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | ENDOCRINE DISRUPTION | BISPHENOL-A | PROLIFERATION | LUMEN FORMATION | Estradiol - analogs & derivatives | Receptors, Estrogen - metabolism | Epithelial Cells - metabolism | Estrogens - pharmacology | Gene Expression - drug effects | Receptors, G-Protein-Coupled - metabolism | Epithelial Cells - drug effects | Humans | Estrogen Antagonists - pharmacology | Immunoblotting | Receptors, Progesterone - genetics | Mammary Glands, Human - metabolism | Quinolines - pharmacology | Estrogen Receptor beta - metabolism | Estrogen Receptor beta - genetics | Cell Transformation, Neoplastic - genetics | Tumor Suppressor Proteins - genetics | Estrogen Receptor alpha - metabolism | Female | Trefoil Factor-1 | Cell Culture Techniques | Estrogen Receptor beta - antagonists & inhibitors | Estradiol - pharmacology | Mammary Glands, Human - drug effects | Phenols - pharmacology | Cell Line | Mammary Glands, Human - cytology | Receptors, Estrogen - genetics | Receptors, Estrogen - antagonists & inhibitors | Estrogen Receptor alpha - antagonists & inhibitors | Reverse Transcriptase Polymerase Chain Reaction | Cell Transformation, Neoplastic - metabolism | Estrogen Receptor Modulators - pharmacology | Microscopy, Confocal | Estrogen Receptor alpha - genetics | Parabens - pharmacology | Receptors, G-Protein-Coupled - antagonists & inhibitors | Benzhydryl Compounds - pharmacology | Receptors, G-Protein-Coupled - genetics | Cell Transformation, Neoplastic - drug effects | Estrogens, Non-Steroidal - pharmacology | Benzodioxoles - pharmacology | Models | Bisphenol-A | Estradiol | Analysis | Transformation | Epithelial cells | Estrogens | Estrogen | Estrogen receptors | 17β-Estradiol | Carcinogenesis | Morphogenesis | Signal transduction | Carcinogens | Xenoestrogens | Mammary gland | Clearing | Deformation mechanisms | Cultures | Breast cancer | Gene expression | Epithelium | Studies | Bisphenol A | Sex hormones | Medical prognosis | Pharmacy | Morphology | Phenols | Breast | Disruption | Three dimensional models | Cancer | Apoptosis | Index Medicus
Journal Article